# A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck

> **NCT02054442** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 52 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT02054442
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2021-03-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02054442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02054442, "A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02054442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*